Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome

Table 4 Risk factors associated with the development of anxiety symptoms in male patients with MDD and comorbid Mets

Variables	Coefficients	Std.error	t	P value	95% confidence interval for EXP (B)
Variables	EXP (B)				Lower	Upper
(constant)	22.596	5.171	4.369	0.000	11.923	33.269
Age (years)	0.569	1.289	0.441	0.665	-2.164	3.301
Duration of disease (months)	-0.108	0.145	-0.747	0.466	-0.415	0.198
Age of onset (years)	-0.558	1.280	-0.436	0.669	-3.271	2.156
HAMD	0.135	0.126	1.515	1.068	0.301	-0.133
TSH, µIU/L	0.372	0.161	2.307	0.035	0.030	0.714
TgAb, IU/L	1.021	0.364	2.802	0.006	0.296	1.747
TPOAb, IU/L	0.001	0.001	0.996	0.334	-0.001	0.002

Note:
HAMD = Hamilton depression rating scale; TSH: Thyroid Stimulating Hormone; TgAb: Thyroglobulin antibody; TPO-Ab: Thyroid peroxidase
Bold indicate significant correlations between components

ISSN: 1471-244X